Xiaomei Y. Lu
Ueruemqi, 830000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Efficacy and safety of combination immunotherapy for locally advanced esophageal carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: June 22, 2026
RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis.
Journal: Science advances
Published: September 12, 2025
ERK1/2 hijack STAT3 via Thr714 phosphorylation to suppress gene expression.
Journal: Cell communication and signaling : CCS
Published: August 11, 2025
5-FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10-Mediated PD-L1 Shedding and Tumour Microenvironment Remodelling.
Journal: Immunology
Published: June 15, 2025
Divergent roles of PKM2 in regulating PD-L1 and PD-L2 expression and their implications in human and mouse cancer models.
Journal: Acta biochimica et biophysica Sinica
Published: February 21, 2025
PSD3, regulated by PKM2, endows growth and metastasis advantages in esophageal squamous cell carcinoma by modulating EMT progression.
Journal: Scientific reports
Published: July 28, 2024
An accurate and convenient method for Mycoplasma pneumoniae via one-step LAMP-CRISPR/Cas12b detection platform.
Journal: Frontiers in cellular and infection microbiology
Published: March 29, 2024
LEPRE1 shapes a non-flamed tumour immune landscape and predicts the prognosis in esophageal squamous cell carcinoma.
Journal: Clinical and translational medicine
Published: August 01, 2023
Positioning determines function: Wandering PKM2 performs different roles in tumor cells.
Journal: Cell biology international
Published: July 17, 2023
In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized.
Journal: Heliyon
Published: June 12, 2023
Last Updated: 09/26/2026